China approves the first brain implant that controls a robotic glove with thought

China approves the first brain implant that controls a robotic glove with thought
China took a step that seemed reserved for science fiction: in August 2026 it authorized the commercial use of NEO, a brain implant that allows a person with paralysis in one hand to move a robotic glove with thought alone. The decision takes it out of clinical trials and takes it to regular hospitals.
NEO belongs to the field of brain-computer interfaces (BCIs), systems that translate neural signals into commands for external devices. Unlike projects that live in papers or laboratory tests, this one already has the regulatory green light for mass clinical use.
You may also likeMicrosoft services almost restored after 24 hours of outage
The operational difference is enormous. While most of the world's BCIs are still confined to pilot tests – Neuralink, Synchron and others – NEO enters the Chinese health system as a prescribable device. This reduces the distance between innovation and the real patient.
For a person with spinal cord injury or stroke, the promise is concrete: regain the ability to grasp objects, eat, or write without moving a muscle. It's not an external exoskeleton; it's a direct neural signal that is decoded in motion.
The global BCI sector moved about $1.5 billion in 2024 and is projected to exceed $6 billion by 2032. The Chinese authorization changes the map: until now, the regulatory leadership was held by the United States, but now Asia is accelerating the pace.
Sources: [Generation AI (@GeneracionIA)](https://t.me/s/GeneracionIA) — original report. Market context: [Precedence Research — Brain Computer Interface Market 2024](https://www.precedenceresearch.com/brain-computer-interface-market). Image: Reuters.
You may also likeDemocrats push to scrutinize Trump's AI policy